New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2012
18:44 EDTKV.A, HOLXKV Pharmaceutical secures $85M loan for payments under reorganization plan
K-V Pharmaceutical announced that it has received a commitment from lenders led by an affiliate of Silver Point Finance for $85M in senior secured post-petition debtor-in-possession financing, which the company intends to use to, among other things, satisfy the terms of its recently filed settlement agreement with Hologic (HOLX), provide additional financial flexibility during the pendency of the company's Chapter 11 proceeding and fund certain payments under a proposed reorganization plan. The new DIP financing, the Hologic Settlement and the reorganization plan are each subject to approval of the U. S. Bankruptcy Court for the Southern District of New York. The Hologic settlement confirms K-V's continued ownership of Makena and will resolve all bankruptcy related disputes between K-V and Hologic, and provides for mutual releases of all claims between the parties. Under the proposed reorganization plan, K-V expects to emerge from Chapter 11 with its entire product portfolio, including Makena, Clindesse, Gynazole-1 and Evamist.
News For A;HOLX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2015
16:27 EDTAAgilent will will no longer include orders in financial reporting
Agilent Technologies announced it will no longer report orders in its periodic filings with the SEC or its quarterly earnings press releases, effective immediately. This change reflects feedback from several of the company's largest shareholders, and was also driven by the fact that Agilent was the only company among its peers to report orders. The other financial metrics included in the company's reporting provide comprehensive detail about Agilent's performance.
10:00 EDTHOLXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:32 EDTHOLXHologic upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Jack Meehan upgraded Hologic to Equal Weight citing improvement in 3D mammography placements. The analyst keeps a $40 price target for shares.
August 28, 2015
07:12 EDTHOLXWilliam Blair names 21 stocks best positioned for volatile markets
Subscribe for More Information
August 26, 2015
11:01 EDTAAgilent partners with Weill Cornell Medical College for ALS research
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use